img

Global Sunitinib Malate Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sunitinib Malate Market Research Report 2024

Sunitinib Malate is the orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.
According to Mr Accuracy reports new survey, global Sunitinib Malate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029.
Key manufacturers engaged in the Sunitinib Malate industry include Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific, Target Molecule Corp., CSPC, Qilu Pharmaceutical and Hansoh Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sunitinib Malate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sunitinib Malate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sunitinib Malate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer Sutent
Topcare pharmaceutical Co., Ltd
Nanjing First Pharmaceutical Co., Ltd.
J&K Scientific
Target Molecule Corp.
CSPC
Qilu Pharmaceutical
Hansoh Pharma
Segment by Type
12.5mg
37.5mg
50mg

Segment by Application


Advanced Kidney Cancer
GIST (Gastrointestinal Stromal Tumor)
Pancreatic Neuroendocrine Tumors

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Sunitinib Malate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Sunitinib Malate Market Overview
1.1 Product Overview and Scope of Sunitinib Malate
1.2 Sunitinib Malate Segment by Type
1.2.1 Global Sunitinib Malate Market Value Comparison by Type (2024-2034)
1.2.2 12.5mg
1.2.3 37.5mg
1.2.4 50mg
1.3 Sunitinib Malate Segment by Application
1.3.1 Global Sunitinib Malate Market Value by Application: (2024-2034)
1.3.2 Advanced Kidney Cancer
1.3.3 GIST (Gastrointestinal Stromal Tumor)
1.3.4 Pancreatic Neuroendocrine Tumors
1.4 Global Sunitinib Malate Market Size Estimates and Forecasts
1.4.1 Global Sunitinib Malate Revenue 2018-2029
1.4.2 Global Sunitinib Malate Sales 2018-2029
1.4.3 Global Sunitinib Malate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sunitinib Malate Market Competition by Manufacturers
2.1 Global Sunitinib Malate Sales Market Share by Manufacturers (2018-2024)
2.2 Global Sunitinib Malate Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Sunitinib Malate Average Price by Manufacturers (2018-2024)
2.4 Global Sunitinib Malate Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Sunitinib Malate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sunitinib Malate, Product Type & Application
2.7 Sunitinib Malate Market Competitive Situation and Trends
2.7.1 Sunitinib Malate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sunitinib Malate Players Market Share by Revenue
2.7.3 Global Sunitinib Malate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sunitinib Malate Retrospective Market Scenario by Region
3.1 Global Sunitinib Malate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sunitinib Malate Global Sunitinib Malate Sales by Region: 2018-2029
3.2.1 Global Sunitinib Malate Sales by Region: 2018-2024
3.2.2 Global Sunitinib Malate Sales by Region: 2024-2029
3.3 Global Sunitinib Malate Global Sunitinib Malate Revenue by Region: 2018-2029
3.3.1 Global Sunitinib Malate Revenue by Region: 2018-2024
3.3.2 Global Sunitinib Malate Revenue by Region: 2024-2029
3.4 North America Sunitinib Malate Market Facts & Figures by Country
3.4.1 North America Sunitinib Malate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sunitinib Malate Sales by Country (2018-2029)
3.4.3 North America Sunitinib Malate Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sunitinib Malate Market Facts & Figures by Country
3.5.1 Europe Sunitinib Malate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sunitinib Malate Sales by Country (2018-2029)
3.5.3 Europe Sunitinib Malate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sunitinib Malate Market Facts & Figures by Country
3.6.1 Asia Pacific Sunitinib Malate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sunitinib Malate Sales by Country (2018-2029)
3.6.3 Asia Pacific Sunitinib Malate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sunitinib Malate Market Facts & Figures by Country
3.7.1 Latin America Sunitinib Malate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sunitinib Malate Sales by Country (2018-2029)
3.7.3 Latin America Sunitinib Malate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sunitinib Malate Market Facts & Figures by Country
3.8.1 Middle East and Africa Sunitinib Malate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sunitinib Malate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sunitinib Malate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sunitinib Malate Sales by Type (2018-2029)
4.1.1 Global Sunitinib Malate Sales by Type (2018-2024)
4.1.2 Global Sunitinib Malate Sales by Type (2024-2029)
4.1.3 Global Sunitinib Malate Sales Market Share by Type (2018-2029)
4.2 Global Sunitinib Malate Revenue by Type (2018-2029)
4.2.1 Global Sunitinib Malate Revenue by Type (2018-2024)
4.2.2 Global Sunitinib Malate Revenue by Type (2024-2029)
4.2.3 Global Sunitinib Malate Revenue Market Share by Type (2018-2029)
4.3 Global Sunitinib Malate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sunitinib Malate Sales by Application (2018-2029)
5.1.1 Global Sunitinib Malate Sales by Application (2018-2024)
5.1.2 Global Sunitinib Malate Sales by Application (2024-2029)
5.1.3 Global Sunitinib Malate Sales Market Share by Application (2018-2029)
5.2 Global Sunitinib Malate Revenue by Application (2018-2029)
5.2.1 Global Sunitinib Malate Revenue by Application (2018-2024)
5.2.2 Global Sunitinib Malate Revenue by Application (2024-2029)
5.2.3 Global Sunitinib Malate Revenue Market Share by Application (2018-2029)
5.3 Global Sunitinib Malate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer Sutent
6.1.1 Pfizer Sutent Corporation Information
6.1.2 Pfizer Sutent Description and Business Overview
6.1.3 Pfizer Sutent Sunitinib Malate Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Sutent Sunitinib Malate Product Portfolio
6.1.5 Pfizer Sutent Recent Developments/Updates
6.2 Topcare pharmaceutical Co., Ltd
6.2.1 Topcare pharmaceutical Co., Ltd Corporation Information
6.2.2 Topcare pharmaceutical Co., Ltd Description and Business Overview
6.2.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Topcare pharmaceutical Co., Ltd Sunitinib Malate Product Portfolio
6.2.5 Topcare pharmaceutical Co., Ltd Recent Developments/Updates
6.3 Nanjing First Pharmaceutical Co., Ltd.
6.3.1 Nanjing First Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Nanjing First Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product Portfolio
6.3.5 Nanjing First Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 J&K Scientific
6.4.1 J&K Scientific Corporation Information
6.4.2 J&K Scientific Description and Business Overview
6.4.3 J&K Scientific Sunitinib Malate Sales, Revenue and Gross Margin (2018-2024)
6.4.4 J&K Scientific Sunitinib Malate Product Portfolio
6.4.5 J&K Scientific Recent Developments/Updates
6.5 Target Molecule Corp.
6.5.1 Target Molecule Corp. Corporation Information
6.5.2 Target Molecule Corp. Description and Business Overview
6.5.3 Target Molecule Corp. Sunitinib Malate Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Target Molecule Corp. Sunitinib Malate Product Portfolio
6.5.5 Target Molecule Corp. Recent Developments/Updates
6.6 CSPC
6.6.1 CSPC Corporation Information
6.6.2 CSPC Description and Business Overview
6.6.3 CSPC Sunitinib Malate Sales, Revenue and Gross Margin (2018-2024)
6.6.4 CSPC Sunitinib Malate Product Portfolio
6.6.5 CSPC Recent Developments/Updates
6.7 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Corporation Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical Sunitinib Malate Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Qilu Pharmaceutical Sunitinib Malate Product Portfolio
6.7.5 Qilu Pharmaceutical Recent Developments/Updates
6.8 Hansoh Pharma
6.8.1 Hansoh Pharma Corporation Information
6.8.2 Hansoh Pharma Description and Business Overview
6.8.3 Hansoh Pharma Sunitinib Malate Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Hansoh Pharma Sunitinib Malate Product Portfolio
6.8.5 Hansoh Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sunitinib Malate Industry Chain Analysis
7.2 Sunitinib Malate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sunitinib Malate Production Mode & Process
7.4 Sunitinib Malate Sales and Marketing
7.4.1 Sunitinib Malate Sales Channels
7.4.2 Sunitinib Malate Distributors
7.5 Sunitinib Malate Customers
8 Sunitinib Malate Market Dynamics
8.1 Sunitinib Malate Industry Trends
8.2 Sunitinib Malate Market Drivers
8.3 Sunitinib Malate Market Challenges
8.4 Sunitinib Malate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Sunitinib Malate Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Sunitinib Malate Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Sunitinib Malate Market Competitive Situation by Manufacturers in 2022
Table 4. Global Sunitinib Malate Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Sunitinib Malate Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Sunitinib Malate Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Sunitinib Malate Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Sunitinib Malate Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Sunitinib Malate, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Sunitinib Malate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sunitinib Malate, Product Type & Application
Table 12. Global Key Manufacturers of Sunitinib Malate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sunitinib Malate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sunitinib Malate as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sunitinib Malate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Sunitinib Malate Sales by Region (2018-2024) & (K Units)
Table 18. Global Sunitinib Malate Sales Market Share by Region (2018-2024)
Table 19. Global Sunitinib Malate Sales by Region (2024-2029) & (K Units)
Table 20. Global Sunitinib Malate Sales Market Share by Region (2024-2029)
Table 21. Global Sunitinib Malate Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Sunitinib Malate Revenue Market Share by Region (2018-2024)
Table 23. Global Sunitinib Malate Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Sunitinib Malate Revenue Market Share by Region (2024-2029)
Table 25. North America Sunitinib Malate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Sunitinib Malate Sales by Country (2018-2024) & (K Units)
Table 27. North America Sunitinib Malate Sales by Country (2024-2029) & (K Units)
Table 28. North America Sunitinib Malate Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Sunitinib Malate Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Sunitinib Malate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Sunitinib Malate Sales by Country (2018-2024) & (K Units)
Table 32. Europe Sunitinib Malate Sales by Country (2024-2029) & (K Units)
Table 33. Europe Sunitinib Malate Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Sunitinib Malate Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Sunitinib Malate Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Sunitinib Malate Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Sunitinib Malate Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Sunitinib Malate Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Sunitinib Malate Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Sunitinib Malate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Sunitinib Malate Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Sunitinib Malate Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Sunitinib Malate Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Sunitinib Malate Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Sunitinib Malate Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Sunitinib Malate Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Sunitinib Malate Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Sunitinib Malate Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Sunitinib Malate Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Sunitinib Malate Sales (K Units) by Type (2018-2024)
Table 51. Global Sunitinib Malate Sales (K Units) by Type (2024-2029)
Table 52. Global Sunitinib Malate Sales Market Share by Type (2018-2024)
Table 53. Global Sunitinib Malate Sales Market Share by Type (2024-2029)
Table 54. Global Sunitinib Malate Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Sunitinib Malate Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Sunitinib Malate Revenue Market Share by Type (2018-2024)
Table 57. Global Sunitinib Malate Revenue Market Share by Type (2024-2029)
Table 58. Global Sunitinib Malate Price (US$/Unit) by Type (2018-2024)
Table 59. Global Sunitinib Malate Price (US$/Unit) by Type (2024-2029)
Table 60. Global Sunitinib Malate Sales (K Units) by Application (2018-2024)
Table 61. Global Sunitinib Malate Sales (K Units) by Application (2024-2029)
Table 62. Global Sunitinib Malate Sales Market Share by Application (2018-2024)
Table 63. Global Sunitinib Malate Sales Market Share by Application (2024-2029)
Table 64. Global Sunitinib Malate Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Sunitinib Malate Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Sunitinib Malate Revenue Market Share by Application (2018-2024)
Table 67. Global Sunitinib Malate Revenue Market Share by Application (2024-2029)
Table 68. Global Sunitinib Malate Price (US$/Unit) by Application (2018-2024)
Table 69. Global Sunitinib Malate Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Sutent Corporation Information
Table 71. Pfizer Sutent Description and Business Overview
Table 72. Pfizer Sutent Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Sutent Sunitinib Malate Product
Table 74. Pfizer Sutent Recent Developments/Updates
Table 75. Topcare pharmaceutical Co., Ltd Corporation Information
Table 76. Topcare pharmaceutical Co., Ltd Description and Business Overview
Table 77. Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Topcare pharmaceutical Co., Ltd Sunitinib Malate Product
Table 79. Topcare pharmaceutical Co., Ltd Recent Developments/Updates
Table 80. Nanjing First Pharmaceutical Co., Ltd. Corporation Information
Table 81. Nanjing First Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product
Table 84. Nanjing First Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. J&K Scientific Corporation Information
Table 86. J&K Scientific Description and Business Overview
Table 87. J&K Scientific Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. J&K Scientific Sunitinib Malate Product
Table 89. J&K Scientific Recent Developments/Updates
Table 90. Target Molecule Corp. Corporation Information
Table 91. Target Molecule Corp. Description and Business Overview
Table 92. Target Molecule Corp. Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Target Molecule Corp. Sunitinib Malate Product
Table 94. Target Molecule Corp. Recent Developments/Updates
Table 95. CSPC Corporation Information
Table 96. CSPC Description and Business Overview
Table 97. CSPC Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. CSPC Sunitinib Malate Product
Table 99. CSPC Recent Developments/Updates
Table 100. Qilu Pharmaceutical Corporation Information
Table 101. Qilu Pharmaceutical Description and Business Overview
Table 102. Qilu Pharmaceutical Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Qilu Pharmaceutical Sunitinib Malate Product
Table 104. Qilu Pharmaceutical Recent Developments/Updates
Table 105. Hansoh Pharma Corporation Information
Table 106. Hansoh Pharma Description and Business Overview
Table 107. Hansoh Pharma Sunitinib Malate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Hansoh Pharma Sunitinib Malate Product
Table 109. Hansoh Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Sunitinib Malate Distributors List
Table 113. Sunitinib Malate Customers List
Table 114. Sunitinib Malate Market Trends
Table 115. Sunitinib Malate Market Drivers
Table 116. Sunitinib Malate Market Challenges
Table 117. Sunitinib Malate Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sunitinib Malate
Figure 2. Global Sunitinib Malate Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Sunitinib Malate Market Share by Type in 2022 & 2029
Figure 4. 12.5mg Product Picture
Figure 5. 37.5mg Product Picture
Figure 6. 50mg Product Picture
Figure 7. Global Sunitinib Malate Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Sunitinib Malate Market Share by Application in 2022 & 2029
Figure 9. Advanced Kidney Cancer
Figure 10. GIST (Gastrointestinal Stromal Tumor)
Figure 11. Pancreatic Neuroendocrine Tumors
Figure 12. Global Sunitinib Malate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sunitinib Malate Market Size (2018-2029) & (US$ Million)
Figure 14. Global Sunitinib Malate Sales (2018-2029) & (K Units)
Figure 15. Global Sunitinib Malate Average Price (US$/Unit) & (2018-2029)
Figure 16. Sunitinib Malate Report Years Considered
Figure 17. Sunitinib Malate Sales Share by Manufacturers in 2022
Figure 18. Global Sunitinib Malate Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Sunitinib Malate Players: Market Share by Revenue in 2022
Figure 20. Sunitinib Malate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Sunitinib Malate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Sunitinib Malate Sales Market Share by Country (2018-2029)
Figure 23. North America Sunitinib Malate Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Sunitinib Malate Sales Market Share by Country (2018-2029)
Figure 27. Europe Sunitinib Malate Revenue Market Share by Country (2018-2029)
Figure 28. Germany Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Sunitinib Malate Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Sunitinib Malate Revenue Market Share by Region (2018-2029)
Figure 35. China Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Sunitinib Malate Sales Market Share by Country (2018-2029)
Figure 46. Latin America Sunitinib Malate Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Sunitinib Malate Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Sunitinib Malate Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Sunitinib Malate Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Sunitinib Malate by Type (2018-2029)
Figure 56. Global Revenue Market Share of Sunitinib Malate by Type (2018-2029)
Figure 57. Global Sunitinib Malate Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Sunitinib Malate by Application (2018-2029)
Figure 59. Global Revenue Market Share of Sunitinib Malate by Application (2018-2029)
Figure 60. Global Sunitinib Malate Price (US$/Unit) by Application (2018-2029)
Figure 61. Sunitinib Malate Value Chain
Figure 62. Sunitinib Malate Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed